Search results
15 lis 2023 · This version of the Guidelines gives recommendations on CV risk stratification as well as on screening, diagnosis, and treatment of CVD in patients with diabetes. Based on evidence from large CVOTs, the current Guidelines provide clear recommendations on how to reduce cardiovascular risk in patients with diabetes and how to treat patients with ...
European Society of Cardiology. Guidelines. Clinical Practice Guidelines. 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases. Full Text. Access full text on Journal website. Back to ESC Clinical Practice Guidelines resources. Your access to the latest cardiovascular news, science, tools and resources.
25 sie 2023 · The current European Society of Cardiology (ESC) Guidelines on the management of cardiovascular disease in patients with diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes based on data published until end of January 2023.
What is new in the 2019 Guidelines? Reclassification of CV risk in diabetes. New treatment algorithms with glucose-lowering agents for management/prevention of CVD. New recommendations regarding the role of aspirin and NOACs / Duration of DAPT post-ACS in diabetes. Choice of revascularization techniques.
31 sie 2019 · 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) Francesco Cosentino.
7 sty 2020 · DOI: 10.1093/eurheartj/ehz486. Keywords: Guidelines; cardiovascular diseases; cardiovascular risk assessment; diabetes mellitus; epidemiology; impaired glucose tolerance; patient management; patient-centred care; pharmacological treatment; prevention; revascularization; risk factors.
14 paź 2023 · 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023 Oct 14;44 (39):4043-4140. doi: 10.1093/eurheartj/ehad192.
